Compositions and methods for controlling pupil dilation comprising phentolamine

Details for Australian Patent Application No. 2010310788 (hide)

Owner Allergan, Inc.

Inventors Likitlersuang, Sukhon; Parashar, Ajay P.; Pujara, Chetan P.

Agent Davies Collison Cave

Pub. Number AU-A-2010310788

PCT Pub. Number WO2011/050018

Priority 61/321,669 07.04.10 US; 61/253,175 20.10.09 US

Filing date 20 October 2010

Wipo publication date 28 April 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/417 (2006.01)

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/050018 Priority application(s): WO2011/050018

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310800-Alpha adrenergic receptor modulators

2010310786-AKT inhibitors